13F Data
Security · CUSIP 98422T100

Xilio Therapeutics Inc.

COM · institutional ownership from 13F filings
13F holders
1
Shares held
650.4K
Value held
$6.2M
New / sold out
0 / 0
Added / reduced
0 / 0
net 0 shares

13F holders by quarter

Q4 2021: 43Q1 2022: 42Q2 2022: 34Q3 2022: 30Q4 2022: 29Q1 2023: 33Q2 2023: 33Q3 2023: 32Q4 2023: 35Q1 2024: 32Q2 2024: 33Q3 2024: 34Q4 2024: 36Q1 2025: 36Q2 2025: 36Q3 2025: 36Q4 2025: 37Q1 2026: 1Q2 2026: 1Q3 2026: 1
Q4 2021Q3 2026

Net shares bought by existing holders

Q4 2021: 16.2MQ1 2022: -217.5KQ2 2022: -893.2KQ3 2022: -1.3MQ4 2022: -262.5KQ1 2023: 145.5KQ2 2023: -69.8KQ3 2023: -141.8KQ4 2023: -778.8KQ1 2024: -3.4MQ2 2024: 1.6MQ3 2024: 1.4MQ4 2024: -174.1KQ1 2025: -3.3MQ2 2025: 1.3MQ3 2025: -1.7MQ4 2025: 18.0MQ1 2026: -37.8MQ2 2026: 0Q3 2026: 0
Q4 2021Q3 2026

Top holders · Q2 2026

ManagerSharesValue% of portfolio
GILEAD SCIENCES, INC.650,389$6.2M0.38%

Biggest buyers

Nothing to show.

Biggest sellers

Nothing to show.